Literature DB >> 8825929

Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria.

G Lundin1, J Hashemi, Y Floderus, S Thunell, E Sagen, A Laegreid, W Wassif, T Peters, M Anvret.   

Abstract

We have detected four different mutations in the porphobilinogen deaminase (PBGD) gene in acute intermittent porphyria (AIP) families from England, Norway, and Sweden. A splicing mutation in the first position of intron 8 (Int8 + 1) was found in a family from England and a missense mutation in exon 12 (Glu250) was detected in a Norwegian family. Two mutations were identified in Swedish families, one splicing mutation in the first position of intron 3 (Int3 + 1) and one missense mutation in exon 8 (Pro119).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8825929      PMCID: PMC1051782          DOI: 10.1136/jmg.32.12.979

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  Molecular heterogeneity of acute intermittent porphyria: identification of four additional mutations resulting in the CRIM-negative subtype of the disease.

Authors:  M H Delfau; C Picat; F De Rooij; G Voortman; J C Deybach; Y Nordmann; B Grandchamp
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

2.  Acute intermittent porphyria caused by an arginine to histidine substitution (R26H) in the cofactor-binding cleft of porphobilinogen deaminase.

Authors:  D H Llewellyn; S Whatley; G H Elder
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

3.  Two novel mutations of the porphobilinogen deaminase gene in acute intermittent porphyria.

Authors:  X F Gu; F de Rooij; E de Baar; M Bruyland; W Lissens; Y Nordmann; B Grandchamp
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

4.  Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene.

Authors:  R Kauppinen; S Mustajoki; H Pihlaja; L Peltonen; P Mustajoki
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

5.  Detection of eleven mutations causing acute intermittent porphyria using denaturing gradient gel electrophoresis.

Authors:  X F Gu; F de Rooij; G Voortman; K Te Velde; J C Deybach; Y Nordmann; B Grandchamp
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

6.  Acute intermittent porphyria: diagnostic conundrums.

Authors:  W S Wassif; A C Deacon; Y Floderus; S Thunell; T J Peters
Journal:  Eur J Clin Chem Clin Biochem       Date:  1994-12

7.  Detection of seven point mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria, by direct sequencing of in vitro amplified cDNA.

Authors:  C S Mgone; W G Lanyon; M R Moore; J M Connor
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

8.  Acute intermittent porphyria caused by a G to C mutation in exon 12 of the porphobilinogen deaminase gene that results in exon skipping.

Authors:  M Daimon; K Yamatani; M Igarashi; N Fukase; A Ogawa; M Tominaga; H Sasaki
Journal:  Hum Genet       Date:  1993-12       Impact factor: 4.132

9.  Detection of a high mutation frequency in exon 12 of the porphobilinogen deaminase gene in patients with acute intermittent porphyria.

Authors:  C S Mgone; W G Lanyon; M R Moore; G V Louie; J M Connor
Journal:  Hum Genet       Date:  1993-12       Impact factor: 4.132

10.  Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria.

Authors:  J S Lee; M Anvret
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more
  3 in total

1.  Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria.

Authors:  H Puy; J C Deybach; J Lamoril; A M Robreau; V Da Silva; L Gouya; B Grandchamp; Y Nordmann
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

2.  Acute intermittent porphyria in Argentina: an update.

Authors:  Gabriela Nora Cerbino; Esther Noemí Gerez; Laura Sabina Varela; Viviana Alicia Melito; Victoria Estela Parera; Alcira Batlle; María Victoria Rossetti
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

3.  Evaluation of Metabolic Changes in Acute Intermittent Porphyria Patients by Targeted Metabolomics.

Authors:  Alex Gomez-Gomez; Paula Aguilera; Klaus Langohr; Gregori Casals; Cristina Pavon; Josep Marcos; Jordi To-Figueras; Oscar J Pozo
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.